Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 394264, 23 pages
Review Article

Nanotechnology-Applied Curcumin for Different Diseases Therapy

1Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran
2Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

Received 4 February 2014; Revised 21 April 2014; Accepted 25 April 2014; Published 5 June 2014

Academic Editor: Yoshinori Marunaka

Copyright © 2014 Negar Ghalandarlaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Curcumin is a lipophilic molecule with an active ingredient in the herbal remedy and dietary spice turmeric. It is used by different folks for treatment of many diseases. Recent studies have discussed poor bioavailability of curcumin because of poor absorption, rapid metabolism, and rapid systemic elimination. Nanotechnology is an emerging field that is potentially changing the way we can treat diseases through drug delivery with curcumin. The recent investigations established several approaches to improve the bioavailability, to increase the plasma concentration, and to enhance the cellular permeability processes of curcumin. Several types of nanoparticles have been found to be suitable for the encapsulation or loading of curcumin to improve its therapeutic effects in different diseases. Nanoparticles such as liposomes, polymeric nanoparticles, micelles, nanogels, niosomes, cyclodextrins, dendrimers, silvers, and solid lipids are emerging as one of the useful alternatives that have been shown to deliver therapeutic concentrations of curcumin. This review shows that curcumin’s therapeutic effects may increase to some extent in the presence of nanotechnology. The presented board of evidence focuses on the valuable special effects of curcumin on different diseases and candidates it for future clinical studies in the realm of these diseases.